Argus analyst David Toung downgraded Catalent to Sell from Buy in light of the pending merger between Catalent and Novo Holdings. The firm will be dropping coverage of Catalent and will remove the stock from its universe of coverage in the next 30 days, the analyst noted.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTLT: